Opening the floodgates: why UroLift is the solution to BPH

Written by: Professor Francis Chinegwundoh MBE
Published: | Updated: 27/03/2019
Edited by: Cal Murphy

UroLift is an attractive option for men with an enlarged prostate gland (also known as BPH) who are experiencing urinary difficulties. It is suitable for most men where tablets are not effective in improving the urinary flow. Renowned consultant urologist Professor Francis Chinegwundoh explains:

What is BPH?

As men age, commonly, the gland called the prostate, which sits under the bladder and has a space in the middle for the urine to pass through, enlarges and squeezes the urethra or ‘waterpipe’. This enlargement is called benign prostate hypertrophy or BPH. Men may experience a slow urinary flow and a need to pass urine more frequently including at night.

 

What is the UroLift procedure?

The UroLift procedure is an innovative way of dealing with the prostate gland; it does not require any cutting of the prostate nor any removal of tissue.  It is what we term ‘minimally invasive’. It may even be done under local anaesthesia.

The urologist places tiny implants to hold the prostate lobes apart, like open curtains on a window, to relieve the compression on the urethra. This allows the urine to flow normally again.

Advantages of UroLift

There are certain advantages to UroLift over other methods of treating the enlarged prostate. It does not cause any new problems with erections or with ejaculation, meaning fertility is not impaired and a normal sex life can continue. Furthermore, it is a day case procedure. A catheter is not necessary. The procedure only takes 20 minutes, which is shorter than other operations, with a short recovery time. It generally takes two weeks for the symptoms of BPH to improve.

Clinical data has shown that the UroLift system is safe and effective in relieving urinary symptoms due to BPH. The effect is durable.

 

Side effects of UroLift

Possible side effects include passing some blood in the urine, a burning sensation whilst voiding, urgency, and pelvic pain. Most symptoms are mild to moderate and settle in two to four weeks.

 

If you are interested in the UroLift procedure, contact your doctor or a specialist. Professor Chinegwundoh offers this treatment – you can book an appointment by visiting his profile.

By Professor Francis Chinegwundoh MBE
Urology

Professor Francis Chinegwundoh MBE is a renowned consultant urologist based in London, who specialises in treating prostate cancer, benign prostate enlargement, erectile dysfunction, and a wide variety of other urological conditions. In addition to treating patients, he is a widely published researcher, lecturer, and professor, actively involved in teaching and also involved in charity work as Chairman of the charity Cancer Black Care and a trustee of Tackle prostate cancer. He was recognised with an MBE in 2013 for services to the NHS.

Since qualifying in medicine in 1984 from the University of London, Professor Chinegwundoh has accrued a wealth of experience and expertise. He obtained a Master of Surgery degree in 1994 and more recently a Master of Medical Law in 2010. He is a Fellow of the Royal College of Surgeons of England and Edinburgh as well as a Fellow of the European Board of Urology. He established and runs the regional prostate low dose brachytherapy service at Barts Health NHS Trust. He has performed over 100 transurethral needle ablation of the prostate for benign prostate enlargement and over 1500 transperineal template prostate biopsies. He is also a medical legal expert.

Professor Chinegwundoh is currently urology lead at Newham University Hospital, Barts Health NHS Trust as well as co-chairman of the Department of Health's Prostate Cancer Advisory Group. He serves as an honorary clinical senior lecturer at Queen Mary’s College, University of London and has been an honorary visiting Professor in the School of Health Sciences, City University, London since December 2014.

View Profile

Overall assessment of their patients


We use cookies on this site to enhance your user experience. Click ‘Enter’ to continue browsing. Enter Cookies policy